These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26813962)

  • 61. Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis.
    Clausen FB; Christiansen M; Steffensen R; Jørgensen S; Nielsen C; Jakobsen MA; Madsen RD; Jensen K; Krog GR; Rieneck K; Sprogøe U; Homburg KM; Grunnet N; Dziegiel MH
    Transfusion; 2012 Apr; 52(4):752-8. PubMed ID: 21995641
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Current trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibility.
    Valsami S; Dimitroulis D; Gialeraki A; Chimonidou M; Politou M
    Asian J Transfus Sci; 2015; 9(2):117-23. PubMed ID: 26420927
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Risks of red blood cell alloimmunization in transfusion-dependent β-thalassemia in Oman: a 25-year experience of a university tertiary care reference center and a literature review.
    Al-Riyami AZ; Al-Muqbali A; Al-Sudiri S; Murthi Panchatcharam S; Zacharia M; Al-Mahrooqi S; Al-Hosni S; Al-Marhoobi A; Daar S
    Transfusion; 2018 Apr; 58(4):871-878. PubMed ID: 29399805
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Foetal Rhesus-D typing added to antenatal screening for infectious diseases and erythrocyte immunisation].
    van der Ploeg CP; Hirschberg HJ; de Haas M; Abbink F
    Ned Tijdschr Geneeskd; 2015; 159():A8315. PubMed ID: 25898866
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A curious case of anti-D antibody titer.
    Hensley JG; Coughlin KP; Klein LL
    J Midwifery Womens Health; 2009; 54(6):497-502. PubMed ID: 19879523
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cost-effectiveness of first trimester non-invasive fetal RHD screening for targeted antenatal anti-D prophylaxis in RhD-negative pregnant women: a model-based analysis.
    Neovius M; Tiblad E; Westgren M; Kublickas M; Neovius K; Wikman A
    BJOG; 2016 Jul; 123(8):1337-46. PubMed ID: 26663771
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Optimal blood grouping and antibody screening for safe transfusion.
    Makarovska-Bojadzieva T; Blagoevska M; Kolevski P; Kostovska S
    Prilozi; 2009 Jul; 30(1):119-28. PubMed ID: 19736535
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Clinical significance of anti-D IgG screening and titer detection in 286 RhD negative pregnant women].
    Liu KL; Li N; Li BJ; Peng JY; Shu XW; Yu YY
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):185-7. PubMed ID: 19292952
    [TBL] [Abstract][Full Text] [Related]  

  • 69. ABO and Rh Antigen Distribution Among Pregnant Women in South Western Uganda.
    Mbalibulha Y; Natukunda B; Livex OA; Ononge S; Kalyango JN; Kajja I
    J Blood Med; 2022; 13():351-355. PubMed ID: 35769868
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A Case of a Newborn With Blocked RhD Antigen and HDFN.
    Wang H; Chen J; Jiang Y
    Lab Med; 2017 Nov; 48(4):381-383. PubMed ID: 29053863
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Occurrence of ABO And RhD Incompatibility with Rh Negative Mothers.
    Izetbegovic S
    Mater Sociomed; 2013 Dec; 25(4):255-8. PubMed ID: 24511269
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Relevance and costs of RHD genotyping in women with a weak D phenotype.
    Laget L; Izard C; Durieux-Roussel E; Gouvitsos J; Dettori I; Chiaroni J; Ferrera-Tourenc V
    Transfus Clin Biol; 2019 Feb; 26(1):27-31. PubMed ID: 29866395
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Timing of RhD-positive red blood cell administration is associated with D-alloimmunization in injured patients.
    Yazer MH; Spinella PC; Sperry J; Triulzi DJ; Leeper C
    Transfusion; 2023 May; 63 Suppl 3():S54-S59. PubMed ID: 37067374
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Patterns of prescription drugs use among pregnant women at Sultan Qaboos University Hospital and Sultan Qaboos University Hospital Family and Community Medicine Clinic, Oman.
    Al-Hamimi JZ; Al Balushi KA
    J Pharm Bioallied Sci; 2016; 8(4):309-313. PubMed ID: 28216955
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women.
    Darlington M; Carbonne B; Mailloux A; Brossard Y; Levy-Mozziconacci A; Cortey A; Maoulida H; Simon T; Rousseau A; Durand-Zaleski I;
    BMC Pregnancy Childbirth; 2018 Dec; 18(1):496. PubMed ID: 30547830
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anti-D Alloimmunization after RhD-Positive Platelet Transfusion in RhD-Negative Women under 55 Years Diagnosed with Acute Leukemia: Results of a Retrospective Study.
    Villalba A; Santiago M; Freiria C; Montesinos P; Gomez I; Fuentes C; Rodriguez-Veiga R; Fernandez JM; Sanz G; Sanz MA; Carpio N; Solves P
    Transfus Med Hemother; 2018 May; 45(3):162-166. PubMed ID: 29928170
    [TBL] [Abstract][Full Text] [Related]  

  • 78. How clinically important are non-D Rh antibodies?
    Healsmith S; Savoia H; Kane SC
    Acta Obstet Gynecol Scand; 2019 Jul; 98(7):877-884. PubMed ID: 30723901
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Fetal RHD Genotyping Using Real-Time Polymerase Chain Reaction Analysis of Cell-Free Fetal DNA in Pregnancy of RhD Negative Women in South of Iran.
    Moezzi L; Keshavarz Z; Ranjbaran R; Aboualizadeh F; Behzad-Behbahani A; Abdullahi M; Ramezani A; Samsami A; Sharifzadeh S
    Int J Fertil Steril; 2016; 10(1):62-70. PubMed ID: 27123202
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A practical and effective strategy in East Asia to prevent anti-D alloimmunization in patients by C/c phenotyping of serologic RhD-negative blood donors.
    Ito S; Ohto H; Ogiyama Y; Irino M; Omokawa S; Shibasaki I; Ogasawara K; Uchikawa M; Nollet KE; Flegel WA
    EJHaem; 2021 Nov; 2(4):750-756. PubMed ID: 35757680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.